Key result
Prevention strategies for chronic non-communicable diseases require a complex approach, including the use of genetic information to define disease risks and personalize medical prevention.
Why the study?
Effective control of chronic non-communicable diseases is an urgent healthcare target, prompting a need to evaluate classical prevention strategies, their transformation, and novel approaches such as personalized genetic risk assessment.
This review emphasizes the importance of integrating classical prevention strategies with modern personalized approaches, such as genetic risk profiling, to effectively control chronic non-communicable diseases.
May expand prevention tactics for non-communicable diseases; leaves open validation before practice change.
One of the most significant and urgent targets of modern healthcare is an effective control of chronic non-communicable diseases. These diseases lead not only to premature death, but also to permanent incapacitation and worsening of life quality. Prophylactic measures have proven to be the most effective method for control of chronic non-communicable diseases. However, in addition to well-known prevention tactics: population, high-risk and secondary prevention strategies, there are currently other approaches. The presented review provides a brief comparison of two “classical” prevention strategies. We analyzed the contribution of each of them to world healthcare, and justified the need for a complex approach to prevention. We studied possible transformation of present strategies and considered other promising approaches developed by some authors. Particular attention is paid to assessing the possibilities and feasibility of genetic information using to define the disease risks and personalize medical prevention.
No takes yet. Share an insight, caveat, or question.
Kobyakova et al. (2019) conducted a review in chronic non-communicable diseases. Prevention strategies was evaluated. Prevention strategies for chronic non-communicable diseases require a complex approach, including the use of genetic information to define disease risks and personalize medical prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: